NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001958

Registered date:01/06/2009

Clinical safety and efficacy of combination of sustained-release morphine and transdermal fentanyl patch to the dyspnea in lung cancer patients

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedlung cancer
Date of first enrollment2009/06/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)administration of susteined-release morphine

Outcome(s)

Primary OutcomeImprovement of dyspnea
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Patients with severe cardiac dysfunction 2. Patients with severe renal or liver dysfunction 3. Patients with increased intracranial pressure 4. Patients with skin disorders such as atopic 5. Patients have a fever of more than 40 degree centigrade 6. Patients with impaired consciousness 7. Other than the orally drug (suppository drug and injection) is administered to patients by drug route of morphine

Related Information

Contact

public contact
Name Akihiro Sakashita
Address Japan
Telephone 078-382-5846
E-mail meidai@med.kobe-u.ac.jp
Affiliation Kobe University Graduate School of Medicine Division of Respiratory Medicine, Department of Internal Medicine
scientific contact
Name Yoshihiro Nishimura
Address , 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan Japan
Telephone 078-382-5111
E-mail
Affiliation Kobe University Graduate School of Medicine Division of Respiratory Medicine, Department of Internal Medicine